Literature DB >> 31132876

Nephroprotective effect of wogonin against cadmium-induced nephrotoxicity via inhibition of oxidative stress-induced MAPK and NF-kB pathway in Sprague Dawley rats.

D Jiao1, Q Jiang2, Y Liu2, L Ji3.   

Abstract

Oxidative stress (OS) is one of the responsible factors for causing renal diseases. For the treatment or prevention of the renal disease, antioxidants use could be a hopeful therapeutic mediation as they block the oxidative reaction along with inflammatory process. Wogonin (Wog) is a plant flavonoid, a pharmacologically active component of Scutellaria baicalensis Georgi (Huang Qui), which exhibits antioxidant activity. In this investigation, we explored the nephroprotective activity of Wog on cadmium (Cd)-induced nephron toxicity in rats. Administering (10 and 20 mg/kg) intraperitoneally diminished Cd-induced anomalies in kidney histology and creatinine and serum urea levels. Wog therapy reduced the Cd-influenced generation of inflammatory mediators, inclusive of tumor necrosis factor alpha, interleukin 6, and interleukin 1 beta. Western blot analysis demonstrated that Wog abolished proinflammatory nuclear factor-kappa B (NF-κB) p65 stimulation, phosphorylation of p38 mitogen-activated protein kinases (MAPKs). In all, Wog demonstrated antioxidative and anti-inflammatory effects in Cd- intoxicated rats by obstructing OS and activation of NF-κB via restricting the stimulation of upstream kinases inclusive of MAPKs.

Entities:  

Keywords:  Antioxidant; apoptosis; cadmium; nephroptotection; nephrotoxicity; wogonin

Mesh:

Substances:

Year:  2019        PMID: 31132876     DOI: 10.1177/0960327119842635

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  7 in total

1.  Evaluation of oxidative stress, inflammation, apoptosis, oxidative DNA damage and metalloproteinases in the lungs of rats treated with cadmium and carvacrol.

Authors:  Kerim Yesildag; Cihan Gur; Mustafa Ileriturk; Fatih Mehmet Kandemir
Journal:  Mol Biol Rep       Date:  2021-11-18       Impact factor: 2.316

2.  Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington's disease via suppressing MAPKs and NF-κB pathways in the striatum.

Authors:  Xiong Yang; Shi-Feng Chu; Zhen-Zhen Wang; Fang-Fang Li; Yu-He Yuan; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2020-11-19       Impact factor: 7.169

3.  Flavonoids Distinctly Stabilize Lymph Endothelial- or Blood Endothelial Disintegration Induced by Colon Cancer Spheroids SW620.

Authors:  Julia Berenda; Claudia Smöch; Christa Stadlbauer; Eva Mittermair; Karin Taxauer; Nicole Huttary; Georg Krupitza; Liselotte Krenn
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411

4.  Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses.

Authors:  Xiaowen Shi; Bin Zhang; Zhenliang Chu; Bingjiang Han; Xueping Zhang; Ping Huang; Jibo Han
Journal:  Cardiovasc Ther       Date:  2021-07-01       Impact factor: 3.023

Review 5.  The Therapeutic Potential of Wogonin Observed in Preclinical Studies.

Authors:  Javad Sharifi-Rad; Jesús Herrera-Bravo; Luis A Salazar; Shabnum Shaheen; Seyed Abdulmajid Ayatollahi; Farzad Kobarfard; Muhammad Imran; Ali Imran; Luísa Custódio; María Dolores López; Mauricio Schoebitz; Miquel Martorell; Manoj Kumar; Hafiz Ansar Rasul Suleria; William C Cho
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-15       Impact factor: 2.629

6.  Study on toxicological effect and the mechanism of cadmium in rice and inorganic cadmium on ICR mice.

Authors:  Xiaoyao Yin; Qian Wu; Wanying Song; Qing Yang; Yongning Wu; Min Fang; Zhiyong Gong
Journal:  Toxicol Res (Camb)       Date:  2021-06-01       Impact factor: 2.680

7.  Current biological and pharmacological updates on wogonin.

Authors:  Sarita Rawat; Gaurav Gupta; Sachchidanand Pathak; Santosh Kumar Singh; Himmat Singh; Anurag Mishra; Ritu Gilhotra; Alaa A A Aljabali; Harish Dureja; Murtaza M Tambuwala; Dinesh K Chellappan; Kamal Dua
Journal:  EXCLI J       Date:  2020-05-13       Impact factor: 4.068

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.